Unparalleled rare cannabinoid expertise
InMed is a leader in the manufacturing and development of rare cannabinoids. Our manufacturing technologies produce several rare cannabinoids for pharmaceutical development and consumer products. We have acquired BayMedica to bring together rare cannabinoid expertise and capabilities like no other.
Delivering high quality, pure rare cannabinoids
Each cannabinoid holds distinctly different active properties. There is no ‘one size fits all’ approach to manufacture every unique cannabinoid. With multiple cannabinoid manufacturing methods, InMed has complete flexibility to select the most appropriate, cost-effective method to produce a high quality, pure rare cannabinoid fit for its intended use.
Producing rare cannabinoids for a variety of uses
InMed’s rare cannabinoids are being applied across a spectrum of uses – from pharmaceutical development to wholesale sales to the consumer health and wellness sector. In addition to our Phase 2 clinical program in dermatology and a second program in glaucoma, our BayMedica division is the leading producer of wholesale CBC cannabinoid for the consumer health and wellness industry. We are researching the therapeutic benefits of several rare cannabinoids and have a growing library of rare cannabinoid analogs for development.
Experienced team with a successful track record
Together, InMed and BayMedica bring extensive know-how in cannabinoid science, manufacturing and development. We’ve combined our complementary expertise to become a leading manufacturer and developer of high-quality rare cannabinoids.
